A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease

Archives of Neurology

Volumn 60, Issue 5, 2003, Pages 722-725

  Zheng, Kangni ^b   Heydari, Bobak ^b   Simon, David K ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MALE; NURR1 GENE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RESTRICTION MAPPING;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LEWY BODY DISEASE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0038326633     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.5.722     Document Type: Article

References (15)

1. Gwinn-Hardy K. Genetics of parkinsonism. Mov Disord. 2002;17:645-656.
2. Backman C, Perlmann T, Wallen A, Hoffer BJ, Morales M. A selective group of dopaminergic neurons express Nurrl in the adult mouse brain. Brain Res. 1999; 851:125-132.
3. Law SW, Conneely OM, DeMayo FJ, O'Malley BW. Identification of a new brain-specific transcription factor, NURR1. Mol Endocrinol. 1992;6:2129-2135.
4. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science. 1997;276:248-250.
5. Le W, Conneely OM, Zou L, et al. Selective agenesis of mesencephalic dopaminergic neurons in Nurrl-deficient mice. Exp Neurol. 1999;159:451-458.
6. Le W, Conneely OM, He Y, Jankovic J, Appel SH. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem. 1999;73:2218-2221.
7. Xu PY, Liang R, Jankovic J, et al. Association of homozygous 7048G7049 variant in the intron six of NURR1 gene with Parkinson's disease. Neurology. 2002; 58:881-884.
8. Buervenich S, Carmine A, Arvidsson M, et al. NURR1 mutations in cases of schizophrenia and manic-depressive disorder. Am J Med Genet. 2000;96:808-813.
9. Lücking CB, Dürr A, Bonifati V, et al, and the French Parkinson's Disease Genetics Study Group. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med. 2000;342:1560-1567.
10. Simon DK, Pulst SM, Sutton JP, Browne SE, Beal MF, Johns DR. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology. 1999;53:1787-1793.
11. Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. JAMA. 1999;281:341-346.
12. Payami H, Zareparsi S, James D, Nutt J. Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol. 2002;59:848-850.
13. O'Neill JP, Rogan PK, Cariello N, Nicklas JA. Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum. Mutat Res. 1998;411:179-214.
14. Mayer K, Ballhausen W, Leistner W, Rott H. Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences. Biochim Biophys Acta. 2000;1502:495-507.
15. Bonifati V, Joosse M, Nicholl DJ, et al. The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases. Neurosci Lett. 1999;274:61-65.